Ajanta Pharma Limited has informed the Exchange about Transcript

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.7%1-day move

₹3033.00

prior close

₹3045.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.7-1.3-1.2-1.3+1.7+3.0+8.1+4.8+6.0+5.0-4.3+3.6+12.9—

Up moveDown movePending

AI summary

Ajanta Pharma has submitted a written transcript of its earnings call held on 5th May 2026 at 4:30 PM. The filing is pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The transcript covers Q4 (January-March) 2025-26 results discussion. The full transcript is available on the company's website at the provided link. This is a routine compliance filing to ensure investor access to the earnings discussion.

Likely market impact

Shareholders and analysts can now review the full earnings call transcript for insights on management commentary, strategy, and Q4 performance details beyond what was covered in the initial earnings announcement.